BDBM300687 N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({[1- (morpholin-4- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 257

SMILES Cc1ccccc1c5nnc(NC(=O)c4ccc(OC(F)(F)F)c(NC(=O)C3(N2CCOCC2)CC3)c4)s5

InChI Key InChIKey=LDKPLJLMCJBGFA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 300687   

TargetProtein Wnt-3a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM300687(N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({...)
Affinity DataIC50: 17nMAssay Description:In preparation of the assay, the two cell lines were plated 24 hours before at 10000 cells per well of a 384 micro titre plate (MTP) in 30 μL gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2019
Entry Details
Go to US Patent

TargetProtein Wnt-3a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM300687(N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({...)
Affinity DataIC50: 5.00E+4nMAssay Description:In preparation of the assay, the two cell lines were plated 24 hours before at 10000 cells per well of a 384 micro titre plate (MTP) in 30 μL gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2019
Entry Details
Go to US Patent